Abutaleb, A., Kottilil, S., & Wilson, E. (2018). Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy. Hepatol Int.
Citação norma ChicagoAbutaleb, Ameer, Shyam Kottilil, and Eleanor Wilson. "Glecaprevir/pibrentasvir Expands Reach While Reducing Cost and Duration of Hepatitis C Virus Therapy." Hepatol Int 2018.
MLA citiranjeAbutaleb, Ameer, Shyam Kottilil, and Eleanor Wilson. "Glecaprevir/pibrentasvir Expands Reach While Reducing Cost and Duration of Hepatitis C Virus Therapy." Hepatol Int 2018.
Opozorilo: Ti citati niso vedno 100% točni.